ATG10 and colorectal carcinoma: Impairing autophagy in CRC cells by reducing ATG10 expression can make them more susceptible to chemotherapeutic agents in vitro and in vivo, which is consistent with the report that miR-27b-3p levels positively correlate with disease-free survival time in CRC patients (138).